Research Article

MAP9 Exhibits Protumor Activities and Immune Escape toward Bladder Cancer by Mediating TGF-β1 Pathway

Figure 5

MAP9 promotes tumor growth in vivo. (a) Immunohistochemistry (IHC) staining of the T24 xenograft tumors. (b) In vivo imaging technology to monitor the growth of T24 xenograft tumors. Xenograft tumors were generated by injecting sh-ctrl or sh-MAP9 T24 cells. (c) MAP9 knockdown increased the growth of T24 xenograft tumors. Xenograft tumors were generated by injecting sh-ctrl or short hairpin ribonucleic acid- (RNA-) MAP9 (sh-MAP9) T24 cells. The growth of the xenograft tumors was determined by volume. Data are presented as the (SD), and paired Student’s -test was employed for data analysis. , , and .
(a)
(b)
(c)